市場調査レポート

商品コード

1442588

生検デバイスの世界市場の評価：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Biopsy Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年03月04日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 228 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,150円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,190円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,284,940円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.70円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の生検デバイスの市場規模は、予測期間中にCAGR 8.03％で成長し、2023年の31億米ドルから、2031年には57億4,000万米ドルに成長すると予測されています。

生検デバイスの市場は、世界の癌罹患率の増加、生検デバイスの設計と機能の進歩、低侵襲処置に対する需要の高まり、規制による支援などの成長要因の影響を受けて成長すると予測されています。さらに、AIと機械学習の統合が生検デバイス産業の継続的な成長と革新において極めて重要な役割を果たすと予想されています。世界レベルでの癌患者数の増加は、生検デバイスの需要を牽引する主要な促進要因です。医療インフラの拡大、診断ラボの増加、正確で迅速な診断による癌疾患負担軽減のための政府による支援も、生検デバイス市場の拡大に寄与する要因です。さらに、人々の癌に対する意識の高まりや診断方法への容易なアクセスも市場成長を後押ししています。

一方で、生検デバイスの使用に伴う感染症のリスクや未発達の医療インフラが市場の成長を阻害する要因のひとつとなっています。生検の過程で感染が広がる可能性は高く、医療従事者だけでなく患者にとっても大きな課題となっています。

生検デバイスの進歩

最近の生検デバイスの進歩は、リキッドバイオプシーと骨生検デバイスを中心に進んでいます。リキッドバイオプシーは体液から腫瘍由来の情報を分析するもので、マイクロフォトニクス、ナノフォトニクス、マイクロフルイディクス技術の発展に支えられ、近年大きな進歩を遂げています。これらの技術は、循環腫瘍RNA、無細胞マイクロRNA、エクソソームなどの分析物の検出を可能にし、非侵襲性、再現性、迅速な結果など、従来の組織生検と比較していくつかの利点を提供します。一方、骨生検デバイスは、検査のために少量の骨サンプルを採取するように設計されており、癌などの疾患の早期発見・診断に役立ちます。骨生検技術における最近の進歩には、革新的な装置の開発、組織採取技術の改善、到達困難な腫瘍部位にアクセスできる磁気針の探求などがあります。

癌患者の増加

癌患者数の増加は、疾患の早期発見と正確な診断の必要性から生検デバイスの需要を増大させています。乳癌、肺癌、白血病などのさまざまな種類の癌の有病率の上昇は、生検デバイスの需要シナリオにプラスの影響を与えています。癌患者数の増加は、放射線被曝の増加、不適切なライフスタイル、長時間労働、ストレスの増加、喫煙、飲酒、避妊の使用をはじめとする多くの要因によるものです。汎米保健機構 (PAN AMERICA HEALTH ORGANIZATION) によると、世界全体で約2,000万人が新たに癌に罹患し、1,000万人が癌に関連して死亡しています。このことは、医療システム、個人、地域社会に多大な負担をかけています。残念ながら、この負担は今後20年間で60％増加すると予測されています。つまり、2040年までに世界中で約3,000万人の癌患者が新たに発生する可能性があり、もっとも顕著な増加は低・中所得国で起こると予測されています。

北米が主要地域に

北米は医療支出が高く、R&Dのエコシステムが確立されており、疾患の早期発見に重点を置いています。また、北米は強力な医療インフラ、確立された保険・自己負担制度、積極的な規制の枠組みを有しており、これが同地域の優位性を強めています。また、この地域は癌やその他の慢性疾患の有病率が高く、生検デバイスの旺盛な需要につながっています。さらに、北米には主要な参入企業が存在し、規制当局の承認に重点を置いていることも、生検デバイス市場における北米の優位性に寄与しています。

当レポートでは、世界の生検デバイスの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

市場規模・予測
製品タイプ別
- 針ベース生検ガン
- 生検誘導システム
- 生検鉗子
- 生検針
- その他
用途別
- 乳房生検
- 肺生検
- 結腸直腸生検
- 前立腺生検
- その他
エンドユーザー別
- 病院
- 専門腫瘍センター
- 診断センター
- 研究機関
地域別
- 北米
- 欧州
- アジア太平洋
- 南米
- 中東・アフリカ
企業別市場シェア

第5章世界の生検デバイス市場の展望：地域別

北米
欧州
アジア太平洋
南米
中東・アフリカ

第6章市場マッピング

製品タイプ別
用途別
エンドユーザー別
地域別

第7章マクロ環境と産業構造

需要供給分析
輸出入分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長抑制要因 (課題・抑制要因)

第9章法規制の枠組み・イノベーション

臨床試験
特許環境
規制承認
イノベーション・新興技術

第10章主要企業の情勢

市場リーダー上位5社の競合マトリックス
市場リーダー上位5社の市場収益分析
M&A・ジョイントベンチャー (該当する場合)
SWOT分析 (参入5社)

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

Becton, Dickinson and Company
Hologic Inc.
Danaher Corporation
Cook Medical
Boston Scientific Corporation
Argon Medical Devices
B. Braun Melsungen AG
Cardinal Health Inc.
Medtronic PLC
Olympus Corporation

第14章戦略的提言

第15章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 2. Global Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 3. Global Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 4. Global Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 5. Global Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 6. Global Biopsy Devices Market Share (%), By Region, 2017-2031F
Figure 7. North America Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 8. North America Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 9. North America Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 10. North America Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 11. North America Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 12. North America Biopsy Devices Market Share (%), By Country, 2017-2031F
Figure 13. United States Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 14. United States Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 15. United States Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 16. United States Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 17. United States Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 18. Canada Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 19. Canada Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 20. Canada Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 21. Canada Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 22. Canada Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 23. Mexico Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 24. Mexico Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 25. Mexico Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 26. Mexico Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 27. Mexico Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 28. Europe Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 29. Europe Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 30. Europe Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 31. Europe Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 32. Europe Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Biopsy Devices Market Share (%), By Country, 2017-2031F
Figure 34. Germany Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 35. Germany Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 36. Germany Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 37. Germany Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 38. Germany Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 39. France Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 40. France Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 41. France Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 42. France Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 43. France Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 44. Italy Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 45. Italy Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 46. Italy Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 47. Italy Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 48. Italy Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 49. United Kingdom Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 50. United Kingdom Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 51. United Kingdom Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 52. United Kingdom Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 53. United Kingdom Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 54. Russia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 55. Russia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 56. Russia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 57. Russia Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 58. Russia Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 59. Netherlands Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 60. Netherlands Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 61. Netherlands Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 62. Netherlands Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 63. Netherlands Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 64. Spain Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 65. Spain Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 66. Spain Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 67. Spain Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 68. Spain Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 69. Turkey Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 70. Turkey Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 71. Turkey Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 72. Turkey Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 73. Turkey Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 74. Poland Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 75. Poland Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 76. Poland Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 77. Poland Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 78. Poland Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 79. South America Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 80. South America Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 81. South America Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 82. South America Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 83. South America Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 84. South America Biopsy Devices Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 86. Brazil Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 87. Brazil Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 88. Brazil Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 89. Brazil Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 90. Argentina Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 91. Argentina Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 92. Argentina Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 93. Argentina Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 94. Argentina Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 95. Asia-Pacific Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 96. Asia-Pacific Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 97. Asia-Pacific Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 98. Asia-Pacific Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 99. Asia-Pacific Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 100. Asia-Pacific Biopsy Devices Market Share (%), By Country, 2017-2031F
Figure 101. India Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 102. India Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 103. India Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 104. India Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 105. India Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 106. China Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 107. China Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 108. China Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 109. China Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 110. China Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 111. Japan Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 112. Japan Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 113. Japan Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 114. Japan Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 115. Japan Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 116. Australia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 117. Australia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 118. Australia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 119. Australia Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 120. Australia Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 121. Vietnam Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 122. Vietnam Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 123. Vietnam Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 124. Vietnam Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 125. Vietnam Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 126. South Korea Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 127. South Korea Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 128. South Korea Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 129. South Korea Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 130. South Korea Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 131. Indonesia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 132. Indonesia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 133. Indonesia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 134. Indonesia Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 135. Indonesia Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 136. Philippines Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 137. Philippines Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 138. Philippines Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 139. Philippines Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 140. Philippines Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 141. Middle East & Africa Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 142. Middle East & Africa Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 143. Middle East & Africa Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 144. Middle East & Africa Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 145. Middle East & Africa Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 146. Middle East & Africa Biopsy Devices Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 148. Saudi Arabia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 149. Saudi Arabia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 150. Saudi Arabia Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 151. Saudi Arabia Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 152. UAE Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 153. UAE Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 154. UAE Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 155. UAE Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 156. UAE Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 157. South Africa Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 158. South Africa Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 159. South Africa Biopsy Devices Market Share (%), By Product Type, 2017-2031F
Figure 160. South Africa Biopsy Devices Market Share (%), By Application, 2017-2031F
Figure 161. South Africa Biopsy Devices Market Share (%), By End-user, 2017-2031F
Figure 162. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11056

Global biopsy devices market is projected to witness a CAGR of 8.03% during the forecast period 2024-2031, growing from USD 3.1 billion in 2023 to USD 5.74 billion in 2031. The biopsy devices market is anticipated to thrive under the influence of growth factors like the growing prevalence of cancer cases globally, design and working advancements in biopsy devices, rising demand for minimally invasive procedures, and regulatory support. Additionally, the integration of artificial intelligence and machine learning is expected to play a pivotal role in the continued growth and innovation of the biopsy devices industry. The rising number of cancer cases at the global level is a major driver that drives the demand for biopsy devices. Growing healthcare infrastructure, a rising number of diagnostic laboratories, and government support for reducing the cancer disease burden through precise and rapid diagnostics are some other factors contributing to the expansion of the biopsy devices market. Furthermore, growing cancer awareness among common people and easy access to diagnostic methods propels market growth.

However, risks of infections associated with the use of biopsy devices and underdeveloped healthcare infrastructure are some factors hindering the growth of this market. During the biopsy process, the chances of infection spreading are high, posing a significant challenge for healthcare professionals as well as the patient.

In May 2023, Argon Medical Devices announced the launch of SuperCore Advantage semi-automatic biopsy instrument which is the newest addition to the company's soft tissue biopsy product portfolio in the United States. The SuperCore Advantage is a disposable soft tissue biopsy instrument that provides a larger tissue sample for more accurate analysis.

Advancements in Biopsy Devices

Recent advancements have been made in biopsy devices, with a focus on liquid biopsies and bone biopsy devices. Liquid biopsies involve the analysis of tumor-derived information from body fluids and have seen significant progress in recent years, supported by the development of microphotonics, nanophotonics, and microfluidics technologies. These technologies enable the detection of analytes, such as circulating tumor RNA, cell-free micro-RNA, and exosomes, and offer several benefits over traditional tissue biopsies, including non-invasiveness, repeatability, and quick results. Meanwhile, bone biopsy devices are designed to remove small bone samples for examination, aiding in the early detection and diagnosis of diseases such as cancer. Recent advancements in bone biopsy technology include the development of innovative devices, improvements in tissue sampling techniques, and the exploration of magnetic needles that can access difficult-to-reach tumor sites.

In November 2023, Illumina Inc. introduced a new version of its TruSight Oncology 500 ctDNA assay, which is designed to provide genomic profiling for circulating tumor DNA (ctDNA) from the blood when tissue-based testing is not possible or to complement tissue-based testing. The new research assay, known as TruSight Oncology 500 ctDNA v2, is a distributed liquid biopsy assay that offers comprehensive genomic profiling (CGP) for ctDNA.

Growing Number of Cancer Cases

The growing number of cancer cases increases the demand for biopsy devices due to the need for early disease detection and accurate diagnosis. The rising prevalence of different types of cancers, such as breast cancer, lung cancer, and leukemia, is positively impacting the demand scenario for biopsy devices. The growing number of cancer cases is attributed to the growing exposure to radiation, inadequate lifestyle, longer working hours, increasing stress, smoking, alcohol consumption, use of contraception, and many more. According to the Pan America Health Organization, globally, around 20 million new cases of cancer and 10 million cancer-related deaths were reported. This puts a considerable burden on health systems, individuals, and communities. Unfortunately, it is predicted that this burden will increase by 60% over the next two decades. This means that by 2040, there could be about 30 million new cases of cancer worldwide, with the most significant increase happening in low- and middle-income countries.

Dominance of Needle-based Biopsy Guns Segment

The needle-based biopsy guns segment dominates the biopsy devices market, with the largest market share. Needle-based biopsy guns are preferred for their precise and minimally invasive tissue collection, aiding in the diagnosis of various medical conditions, especially cancers. Ongoing advancements in needle design for improved accuracy, enhanced safety features, and the integration of imaging technologies, such as ultrasound guidance, are contributing to the growth of this segment. Needle biopsies are minimally invasive procedures that can be performed quickly and with relatively low risk, making them preferable for both patients and healthcare providers. The increasing demand for the gentle and rapid procurement of cell samples for biopsy is also contributing to the growth of this segment.

In October 2023, Praxis Medical obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its EndoCore Endobronchial ultrasound with transbronchial needle aspiration (EBUS-TBNA) fine needle biopsy device. This American medical device company has created the EndoCore EBUS-TBNA biopsy device to aid in the diagnosis and staging of lung cancer. The procedure involves inserting a long, flexible tiny needle through a bronchoscope to perform a biopsy and pathological analysis.

Breast Biopsy Segment to Dominate the Market

The breast cancer segment is expected to dominate the global biopsy devices market. Breast cancer, being the most prevalent type of cancer, takes up the major share in the biopsy device market. The increasing number of breast cancer screening programs and the emergence of liquid biopsy and promising clinical trials are driving this growth. Manufacturers are attempting efforts to cater to the significantly high demand for breast cancer biopsy devices. For instance, in March 2023, TransMed7, LLC announced the first clinical use of VacuPac, which is a new self-contained external vacuum-assist attachment. It comes with a SpeedBird Universal and a Concorde US from the SpeedBird and Concorde families of vacuum-assisted, Single Insertion - Multiple Collection (SIMC) breast biopsy devices. This announcement comes after the previous announcements made by TransMed7 in August 2022 and February 2023 about the first clinical uses of SpeedBird and Concorde biopsy devices. These announcements were made as part of the commercial launch of TransMed7's vacuum assisted, SIMC breast biopsy devices.

North America to be the Dominating Region

North America is the leading region in the biopsy devices market, which is due to several factors. The region has a high healthcare expenditure, a robust research and development ecosystem, and an emphasis on early disease detection. Additionally, North America benefits from a strong healthcare infrastructure, a well-established system for insurance and co-payment, and a proactive regulatory framework, which further reinforces its dominance. The region also has a high prevalence of cancer and other chronic diseases, leading to a robust demand for biopsy devices. Furthermore, the presence of key market players and a focus on regulatory approvals in North America contributes to its leading position in the biopsy devices market.

For instance, in September 2023, Limaca Medical received clearance from the United States Food and Drug Administration (FDA) for its Precision GI endoscopic ultrasound (EUS) biopsy device. The FDA granted the device a breakthrough device designation, and with this new approval, Limaca Medical's automated device can obtain biopsies for definitive pancreatic cancer and gastrointestinal cancer diagnoses more quickly and with less trauma than existing products.

Future Market Scenario (2024 - 2031F)

The regulatory emphasis on biopsy devices is evident in the FDA regulations, which classify biopsy devices used in gastroenterology and urology under three categories, gastroenterology-urology biopsy instruments, endoscopes and accessories, and endoscopic electrosurgical units and accessories. The development of liquid biopsies for cancer screening also requires careful planning to meet regulatory demands, with evolving regulatory pathways and the need for analytical and clinical validation studies. The regulatory strategies for liquid biopsy diagnostics depend on a framework developed by the US Food and Drug Administration, with evolving guidance documents and regulatory approval precedents. The complexity of regulatory permutations for liquid biopsy diagnostics is influenced by specific indications and companion diagnostic claims associated with the products. Conclusively, a rising number of regulatory-approved biopsy devices is anticipated to cultivate healthy competition in the market and contribute to its expansion.

For instance, in November 2023, Single Pass, Inc. announced that it has received a CE Mark under EU MDR for its Kronos Biopsy Closure device. The cautery device is useful in stopping bleeding caused by biopsy tools during co-axial biopsy procedures. It is most used in liver, kidney, lung, and breast biopsy procedures.

Key Players Landscape and Outlook

The key players in the biopsy devices market include both global as well as local companies that operate in the market through a vast network of distributors. Some of the major players in the global biopsy devices market are Becton, Dickinson and Company, Hologic Inc., Danaher Corporation, Cook Medical, Boston Scientific Corporation, Argon Medical Devices, and B. Braun Melsungen AG. These companies are mainly involved in the strategic product development, research, and approval process. Various mergers and acquisitions and collaborations have been observed in recent years, showing the activeness of the key market players.

In June 2023, Quest Diagnostics, a prominent provider of diagnostic information services, announced the completion of its acquisition of Haystack Oncology. The latter is a company that has developed a highly sensitive minimal-residual disease (MRD) testing technology, which is based on circulating tumor DNA (ctDNA). This technology can aid in the early detection of residual or recurring cancer and better inform therapy decisions. Quest plans to incorporate this MRD technology into the development of new blood-based clinical lab services for solid tumor cancers, which will be available starting in 2024.

In March 2023, OraSure collaborated with nRichDx to offer products for researchers who are developing urine-based liquid biopsy assays. Colli-Pee, a sample collection and preservation device, is created by OraSure's subsidiary Novosanis. This device uses a proprietary reagent that allows hygienic collection of a consistent, volumetric first-void urine sample. It also preserves cell-free nucleic acids, such as cfDNA and cfRNA. At the same time, the Revolution Sample Prep System, which has been developed by nRichDX in Irvine, CA, is a semi-automated cfDNA sample prep system. It can process up to 20 mL of urine in a single extraction.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Biopsy Devices Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Product Type
- 4.2.1. Needle-based Biopsy Guns
  - 4.2.1.1. Vacuum-assisted Biopsy (VAB) Devices
  - 4.2.1.2. Fine Needle Aspiration Biopsy (FNAB) Devices
  - 4.2.1.3. Core Needle Biopsy (CNB) Devices
- 4.2.2. Biopsy Guidance Systems
  - 4.2.2.1. Manual
  - 4.2.2.2. Robotic
- 4.2.3. Biopsy Forceps
  - 4.2.3.1. General Biopsy Forceps
  - 4.2.3.2. Hot Biopsy Forceps
- 4.2.4. Biopsy Needles
  - 4.2.4.1. Disposable
  - 4.2.4.2. Reusable
- 4.2.5. Others
4.3. By Application
- 4.3.1. Breast Biopsy
- 4.3.2. Lung Biopsy
- 4.3.3. Colorectal Biopsy
- 4.3.4. Prostate Biopsy
- 4.3.5. Others
4.4. By End-user
- 4.4.1. Hospitals
- 4.4.2. Specialized Oncology Centers
- 4.4.3. Diagnostic Centers
- 4.4.4. Research Institutes
4.5. By Region
- 4.5.1. North America
- 4.5.2. Europe
- 4.5.3. Asia-Pacific
- 4.5.4. South America
- 4.5.5. Middle East and Africa
4.6. By Company Market Share (%), 2023

5. Global Biopsy Devices Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Product Type
  - 5.1.2.1. Needle-based Biopsy Guns
  - 5.1.2.1.1. Vacuum-assisted Biopsy (VAB) Devices
  - 5.1.2.1.2. Fine Needle Aspiration Biopsy (FNAB) Devices
  - 5.1.2.1.3. Core Needle Biopsy (CNB) Devices
  - 5.1.2.2. Biopsy Guidance Systems
  - 5.1.2.2.1. Manual
  - 5.1.2.2.2. Robotic
  - 5.1.2.3. Biopsy Forceps
  - 5.1.2.3.1. General Biopsy Forceps
  - 5.1.2.3.2. Hot Biopsy Forceps
  - 5.1.2.4. Biopsy Needles
  - 5.1.2.4.1. Disposable
  - 5.1.2.4.2. Reusable
  - 5.1.2.5. Others
- 5.1.3. By Application
  - 5.1.3.1. Breast Biopsy
  - 5.1.3.2. Lung Biopsy
  - 5.1.3.3. Colorectal Biopsy
  - 5.1.3.4. Prostate Biopsy
  - 5.1.3.5. Others
- 5.1.4. By End-user
  - 5.1.4.1. Hospitals
  - 5.1.4.2. Specialized Oncology Centers
  - 5.1.4.3. Diagnostic Centers
  - 5.1.4.4. Research Institutes
- 5.1.5. United States*
  - 5.1.5.1. Market Size & Forecast
  - 5.1.5.1.1. By Value
  - 5.1.5.1.2. By Volume
  - 5.1.5.2. By Product Type
  - 5.1.5.2.1. Needle-based Biopsy Guns
  - 5.1.5.2.1.1. Vacuum-assisted Biopsy (VAB) Devices
  - 5.1.5.2.1.2. Fine Needle Aspiration Biopsy (FNAB) Devices
  - 5.1.5.2.1.3. Core Needle Biopsy (CNB) Devices
  - 5.1.5.2.2. Biopsy Guidance Systems
  - 5.1.5.2.2.1. Manual
  - 5.1.5.2.2.2. Robotic
  - 5.1.5.2.3. Biopsy Forceps
  - 5.1.5.2.3.1. General Biopsy Forceps
  - 5.1.5.2.3.2. Hot Biopsy Forceps
  - 5.1.5.2.4. Biopsy Needles
  - 5.1.5.2.4.1. Disposable
  - 5.1.5.2.4.2. Reusable
  - 5.1.5.2.5. Others
  - 5.1.5.3. By Application
  - 5.1.5.3.1. Breast Biopsy
  - 5.1.5.3.2. Lung Biopsy
  - 5.1.5.3.3. Colorectal Biopsy
  - 5.1.5.3.4. Prostate Biopsy
  - 5.1.5.3.5. Others
  - 5.1.5.4. By End-user
  - 5.1.5.4.1. Hospitals
  - 5.1.5.4.2. Specialized Oncology Centers
  - 5.1.5.4.3. Diagnostic Centers
  - 5.1.5.4.4. Research Institutes
- 5.1.6. Canada
- 5.1.7. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Product Type
6.2. By Application
6.3. By End-user
6.4. By Region

7. Macro Environment and Industry Structure

7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Becton, Dickinson and Company
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
13.2. Hologic Inc.
13.3. Danaher Corporation
13.4. Cook Medical
13.5. Boston Scientific Corporation
13.6. Argon Medical Devices
13.7. B. Braun Melsungen AG
13.8. Cardinal Health Inc.
13.9. Medtronic PLC
13.10. Olympus Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

生検デバイスの世界市場の評価：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Biopsy Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の生検デバイス市場の展望

第5章世界の生検デバイス市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章法規制の枠組み・イノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章当社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Biopsy Devices Market Outlook, 2017-2031F

5. Global Biopsy Devices Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

生検デバイスの世界市場の評価：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Biopsy Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の生検デバイス市場の展望

第5章 世界の生検デバイス市場の展望：地域別

第6章 市場マッピング

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 法規制の枠組み・イノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Biopsy Devices Market Outlook, 2017-2031F

5. Global Biopsy Devices Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の生検デバイス市場の展望

第5章世界の生検デバイス市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章法規制の枠組み・イノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章当社について・免責事項